Cardio Diagnostics Holdings (CDIOW) Common Equity (2021 - 2025)
Historic Common Equity for Cardio Diagnostics Holdings (CDIOW) over the last 5 years, with Q3 2025 value amounting to $8.2 million.
- Cardio Diagnostics Holdings' Common Equity rose 12113.84% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 million, marking a year-over-year increase of 12113.84%. This contributed to the annual value of $9.6 million for FY2024, which is 22310.3% up from last year.
- Per Cardio Diagnostics Holdings' latest filing, its Common Equity stood at $8.2 million for Q3 2025, which was up 12113.84% from $9.7 million recorded in Q2 2025.
- In the past 5 years, Cardio Diagnostics Holdings' Common Equity registered a high of $11.4 million during Q1 2025, and its lowest value of $24279.0 during Q3 2021.
- For the 5-year period, Cardio Diagnostics Holdings' Common Equity averaged around $4.8 million, with its median value being $3.2 million (2023).
- Per our database at Business Quant, Cardio Diagnostics Holdings' Common Equity surged by 3933739.79% in 2022 and then crashed by 7610.13% in 2023.
- Cardio Diagnostics Holdings' Common Equity (Quarter) stood at $1.1 million in 2021, then soared by 302.74% to $4.3 million in 2022, then plummeted by 31.23% to $3.0 million in 2023, then surged by 223.1% to $9.6 million in 2024, then decreased by 14.71% to $8.2 million in 2025.
- Its Common Equity was $8.2 million in Q3 2025, compared to $9.7 million in Q2 2025 and $11.4 million in Q1 2025.